Prediction of Patient Hepatic Encephalopathy Risk with Freiburg Index of Post-TIPS Survival Score Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Study

References

• de Franchis R. Developing consensus in portal hypertension. J Hepatol. 1996;25:390–394. doi:10.1016/S0168-8278(96)80127-9
   PubMed Web of Science ®Google Scholar
• Boyer TD, Haskal ZJ. The role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology. 2010;51:306. doi:10.1002/hep.23383
   PubMed Web of Science ®Google Scholar
• Stepanova M, Mishra A, Venkatesan C, Younossi ZM. In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009. Clin Gastroenterol Hepatol. 2012;10:1034–1041.e1031. doi:10.1016/j.cgh.2012.05.016
   PubMed Web of Science ®Google Scholar
• Hernández-Gea V, Procopet B, Giráldez Á, et al. Preemptive-TIPS improves outcome in high-risk variceal bleeding: an Observational Study. Hepatology. 2019;69:282–293. doi:10.1002/hep.30182
   PubMed Web of Science ®Google Scholar
• Riggio O, Angeloni S, Salvatori FM, et al. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol. 2008;103:2738–2746. doi:10.1111/j.1572-0241.2008.02102.x
   PubMed Web of Science ®Google Scholar
• Riggio O, Masini A, Efrati C, et al. Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study. J Hepatol. 2005;42:674–679. doi:10.1016/j.jhep.2004.12.028
   PubMed Web of Science ®Google Scholar
• Flud CR, Duarte-Rojo A. Prognostic implications of minimal/covert hepatic encephalopathy: large-scale Validation Cohort Studies. J Clin Exp Hepatol. 2019;9:112–116. doi:10.1016/j.jceh.2018.04.009
   PubMed Web of Science ®Google Scholar
• Bai M, Qi X, Yang Z, et al. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol. 2011;26:943–951. doi:10.1111/j.1440-1746.2011.06663.x
   PubMed Web of Science ®Google Scholar
• Kaplan DE, Dai F, Aytaman A, et al. Development and performance of an algorithm to estimate the Child-Turcotte-Pugh score from a national electronic healthcare database. Clin Gastroenterol Hepatol. 2015;13:2333–2341.e2331-2336. doi:10.1016/j.cgh.2015.07.010
   Web of Science ®Google Scholar
• Hoekstra LT, de Graaf W, Nibourg GA, et al. Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg. 2013;257:27–36. doi:10.1097/SLA.0b013e31825d5d47
   PubMed Web of Science ®Google Scholar
• Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470. doi:10.1053/jhep.2001.22172
   PubMed Web of Science ®Google Scholar
• Gaba RC, Shah KD, Couture PM, et al. Within-patient temporal variance in MELD score and impact on survival prediction after TIPS creation. Ann Hepatol. 2013;12:797–802. doi:10.1016/S1665-2681(19)31322-5
   PubMed Web of Science ®Google Scholar
• Wang Z, Wu YF, Yue ZD, et al. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. World J Gastroenterol. 2021;27:416–427. doi:10.3748/wjg.v27.i5.416
   PubMed Web of Science ®Google Scholar
• Lin X, Gao F, Wu X, Cai W, Chen X, Huang Z. Efficacy of albumin-bilirubin score to predict hepatic encephalopathy in patients underwent transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol. 2020;33(6):862–871.
   Web of Science ®Google Scholar
• Bettinger D, Sturm L, Pfaff L, et al. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival. J Hepatol. 2021;74(6):1362–1372.
   PubMed Web of Science ®Google Scholar
• Stockhoff L, Schneider H, Tergast TL, Cornberg M, Maasoumy B. Freiburg index of post-TIPS survival (FIPS) a valid prognostic score in patients with cirrhosis but also an advisor against TIPS? J Hepatol. 2021;75(2):487–489. doi:10.1016/j.jhep.2021.02.031
   PubMed Web of Science ®Google Scholar
• Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715–735. doi:10.1002/hep.27210
   PubMed Web of Science ®Google Scholar
• Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005;42(Suppl):S100–S107. doi:10.1016/j.jhep.2004.11.015
   PubMed Web of Science ®Google Scholar
• Van Calster B, Wynants L, Verbeek JFM, et al. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. 2018;74:796–804. doi:10.1016/j.eururo.2018.08.038
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Van Calster B, Steyerberg EW. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ. 2016;352:i6. doi:10.1136/bmj.i6
   PubMed Web of Science ®Google Scholar
• Holmberg L, Vickers A. Evaluation of prediction models for decision-making: beyond calibration and discrimination. PLoS Med. 2013;10:e1001491. doi:10.1371/journal.pmed.1001491
   PubMed Web of Science ®Google Scholar
• Tapper EB. Predicting overt hepatic encephalopathy for the population with cirrhosis. Hepatology. 2019;70:403–409. doi:10.1002/hep.30533
   PubMed Web of Science ®Google Scholar
• Bale A, Pai CG, Shetty S, Balaraju G, Shetty A. Prevalence of and factors associated with minimal hepatic encephalopathy in patients with cirrhosis of liver. J Clin Exp Hepatol. 2018;8:156–161. doi:10.1016/j.jceh.2017.06.005
   PubMed Web of Science ®Google Scholar
• Rowley MW, Choi M, Chen S, Hirsch K, Seetharam AB. Refractory hepatic encephalopathy after elective transjugular intrahepatic portosystemic shunt: risk factors and outcomes with revision. Cardiovasc Intervent Radiol. 2018;41:1765–1772. doi:10.1007/s00270-018-1992-2
   PubMed Web of Science ®Google Scholar
• Fonio P, Discalzi A, Calandri M, et al. Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification. Radiol Med. 2017;122:713–721. doi:10.1007/s11547-017-0770-6
   PubMed Web of Science ®Google Scholar
• Yin X, Zhang F, Guo H, et al. A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients. Sci Rep. 2020;10:9381. doi:10.1038/s41598-020-65227-2
   PubMed Web of Science ®Google Scholar
• Nardelli S, Gioia S, Pasquale C, et al. Cognitive impairment predicts the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Am J Gastroenterol. 2016;111:523–528. doi:10.1038/ajg.2016.29
   PubMed Web of Science ®Google Scholar
• Routhu M, Safka V, Routhu SK, et al. Observational cohort study of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS). Ann Hepatol. 2017;16:140–148. doi:10.5604/16652681.1226932
   PubMed Web of Science ®Google Scholar
• Kalaitzakis E, Björnsson E. Renal function and cognitive impairment in patients with liver cirrhosis. Scand J Gastroenterol. 2007;42:1238–1244. doi:10.1080/00365520701373983
   PubMed Web of Science ®Google Scholar
• Casadaban LC, Parvinian A, Minocha J, et al. Clearing the confusion over hepatic encephalopathy after TIPS creation: incidence, prognostic factors, and clinical outcomes. Dig Dis Sci. 2015;60:1059–1066. doi:10.1007/s10620-014-3391-0
   PubMed Web of Science ®Google Scholar
• Luo X, Zhao M, Wang X, et al. Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft. PLoS One. 2019;14:e0212658. doi:10.1371/journal.pone.0212658
   PubMed Web of Science ®Google Scholar
• Alessandria C, Gaia S, Marzano A, Venon WD, Fadda M, Rizzetto M. Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment. Eur J Gastroenterol Hepatol. 2004;16:607–612. doi:10.1097/00042737-200406000-00015
   PubMed Web of Science ®Google Scholar
• Wong M, Busuttil RW. Surgery in patients with portal hypertension. Clin Liver Dis. 2019;23:755–780. doi:10.1016/j.cld.2019.07.003
   PubMed Web of Science ®Google Scholar
• Mandiga P, Foris LA, Bollu PC. Hepatic encephalopathy. In: StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC.; 2021.
   Google Scholar